In continuation to its intimation dated April 12, 2021, regarding the Earnings Conference Call, Gland Pharma has informed that it has enclosed the details of the Transcript of the Earnings Conference Call on the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2021.
The above information is a part of company’s filings submitted to BSE.